PROCTER & GAMBLE HEALTH L Fair Value
PGHL · Healthcare · Current price ₹5,688
| Method | Fair value | Status |
|---|---|---|
| Residual income | ₹1,343 | 62% ROE fading to 12% over ~20 yrs, on ₹316 book |
| Relative P/E | ₹6,463 | EPS × 32.8 peer-median P/E |
| Graham floor | ₹1,184 | Conservative floor: √(22.5 × EPS × book value/share) |
| Analyst target | ₹7,090 | Street consensus 12-month target price |
Is PROCTER & GAMBLE HEALTH L undervalued?
DocStoX estimates the fair value of PROCTER & GAMBLE HEALTH L at ₹3,536 per share, versus the current market price of ₹5,688. That puts the stock about -37.8% above our fair-value estimate, which we read as "Avoid". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 4 independent methods: Residual income (₹1,343), Relative P/E (₹6,463), Graham floor (₹1,184), Analyst target (₹7,090). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹1,184 (bear) to ₹3,536 (base) to ₹7,090 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
More on PROCTER & GAMBLE HEALTH L
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.